Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study. (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s293. https://doi.org/10.25251/skin.7.supp.293